1. CMU Intellectual Repository

Browsing by Author Beatriz Grinsztejn

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 6 to 24 of 24 < previous 
Issue DateTitleAuthor(s)
1-Jan-2014Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn; Mina C. Hosseinipour; Heather J. Ribaudo; Susan Swindells; Joseph Eron; Ying Q. Chen; Lei Wang; San San Ou; Maija Anderson; Marybeth McCauley; Theresa Gamble; Nagalingeshwaran Kumarasamy; James G. Hakim; Johnstone Kumwenda; Jose H.S. Pilotto; Sheela V. Godbole; Suwat Chariyalertsak; Marineide Gonçalves De Melo; Kenneth H. Mayer; Susan H. Eshleman; Estelle Piwowar-Manning; Joseph Makhema; Lisa A. Mills; Ravindre Panchia; Ian Sanne; Joel Gallant; Irving Hoffman; Taha E. Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Diane Havlir; Myron S. Cohen
1-Jan-2015Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled TrialKathleen Mulligan; David V. Glidden; Peter L. Anderson; Albert Liu; Vanessa McMahan; Pedro Gonzales; Maria Esther Ramirez-Cardich; Sirianong Namwongprom; Piotr Chodacki; Laura Maria Carvalo De Mendonca; Furong Wang; Javier R. Lama; Suwat Chariyalertsak; Juan Vicente Guanira; Susan Buchbinder; Linda Gail Bekker; Mauro Schechter; Valdilea G. Veloso; Robert M. Grant; Lorena Vargas; Jorge Sanchez; Chiang Mai; Pongpun Saokhieo; Kerry Murphy; Hailey Gilmore; Sally Holland; Elizabeth Faber; John Duda; Linda Bewerunge; Elizabeth Batist; Christine Hoskin; Ben Brown; Rio De Janeiro; Carina Beppu-Yoshida; Marcellus Dias Da Costa; Sergio Carlos Assis De Jesus; Jose Roberto Grangeiro Da Silva; Roberta Millan; Brenda Regina De Siqueira Hoagland; Nilo Martinez Fernandes; Lucilene Da Silva Freitas; Beatriz Grinsztejn; Jose Pilotto; Lane Bushman; Jia Hua Zheng; Louis Anthony Guida; Brandon Kline; Pedro Goicochea; Jonathan Manzo; Robert Hance; Jeff McConnell; Patricia Defechereux; Vivian Levy; Malu Robles; Brian Postle; David Burns; James Rooney
1-May-2012Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: Pooled results from the phase 3 double-blind randomized ECHO and THRIVE trialsCalvin J. Cohen; Jean Michel Molina; Pedro Cahn; Bonaventura Clotet; Jan Fourie; Beatriz Grinsztejn; Hao Wu; Margaret A. Johnson; Michael Saag; Khuanchai Supparatpinyo; Herta Crauwels; Eric Lefebvre; Laurence T. Rimsky; Simon Vanveggel; Peter Williams; Katia Boven
1-Aug-2012Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational SettingsThomas B. Campbell; Laura M. Smeaton; N. Kumarasamy; Timothy Flanigan; Karin L. Klingman; Cynthia Firnhaber; Beatriz Grinsztejn; Mina C. Hosseinipour; Johnstone Kumwenda; Umesh Lalloo; Cynthia Riviere; Jorge Sanchez; Marineide Melo; Khuanchai Supparatpinyo; Srikanth Tripathy; Ana I. Martinez; Apsara Nair; Ann Walawander; Laura Moran; Yun Chen; Wendy Snowden; James F. Rooney; Jonathan Uy; Robert T. Schooley; Victor de Gruttola; James Gita Hakim; Edith Swann; Ronald L. Barnett; Barbara Brizz; Yvette Delph; Nikki Gettinger; Ronald T. Mitsuyasu; Susan Eshleman; Steven Safren; Susan A. Fiscus; Adriana Andrade; David W. Haas; Farida Amod; Vladimir Berthaud; Robert C. Bollinger; Yvonne Bryson; David Celentano; David Chilongozi; Myron Cohen; Ann C. Collier; Judith Silverstein Currier; Susan Cu-Uvin; Joseph Eron; Charles Flexner; Joel E. Gallant; Roy M. Gulick; Scott M. Hammer; Irving Hoffman; Peter Kazembe; Newton Kumwenda; Javier R. Lama; Jody Lawrence; Chiedza Maponga; Francis Martinson; Kenneth Mayer; Karin Nielsen; Richard B. Pendame; Bharat Ramratnam; Ian Sanne; Patrice Severe; Thira Sirisanthana; Suniti Solomon; Steve Tabet; Taha Taha; Charles van der Horst; Christine Wanke; Joan Gormley; Cheryl J. Marcus; Beverly Putnam; Smanga Ntshele; Edde Loeliger; Keith A. Pappa; Nancy Webb; David L. Shugarts; Mark A. Winters; Renard S. Descallar; Joseph Steele; Michael Wulfsohn; Farideh Said; Yue Chen; John C. Martin; Norbert Bischofberger; Andrew Cheng; Howard Jaffe; Jabin Sharma; S. Poongulali; Sandra Wagner Cardoso; Deise Lucia Faria; Sima Berendes; Kelly Burke; Rosie Mngqibisa; Cecelia Kanyama; Virginia Kayoyo; Wadzanai P. Samaneka; Anthony Chisada
1-Jan-2021Evaluation of phylogenetic methods for inferring the direction of human immunodeficiency virus (HIV) Transmission: HIV Prevention Trials Network (HPTN) 052Yinfeng Zhang; Chris Wymant; Oliver Laeyendecker; M. Kathryn Grabowski; Matthew Hall; Sarah Hudelson; Estelle Piwowar-Manning; Marybeth McCauley; Theresa Gamble; Mina C. Hosseinipour; Nagalingeswaran Kumarasamy; James G. Hakim; Johnstone Kumwenda; Lisa A. Mills; Breno R. Santos; Beatriz Grinsztejn; Jose H. Pilotto; Suwat Chariyalertsak; Joseph Makhema; Ying Q. Chen; Myron S. Cohen; Christophe Fraser; Susan H. Eshleman
15-Mar-2017Herpes simplex virus type 2 acquisition among HIV-1-infected adults treated with Tenofovir disoproxyl fumarate as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS studyConnie Celum; Ting Hong; Anne Cent; Deborah Donnell; Rhoda Morrow; Jared M. Baeten; Cynthia Firnhaber; Beatriz Grinsztejn; Mina C. Hosseinipour; Umesh Lalloo; Mulinda Nyirenda; Cynthia Riviere; Jorge Sanchez; Breno Santos; Khuanchai Supparatpinyo; James Hakim; N. Kumarasamy; Thomas B. Campbell
15-Apr-2018HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052Philip J. Palumbo; Jessica M. Fogel; Sarah E. Hudelson; Ethan A. Wilson; Stephen Hart; Laura Hovind; Estelle Piwowar-Manning; Carole Wallis; Maria A. Papathanasopoulos; Mariza G. Morgado; Shanmugam Saravanan; Srikanth Tripathy; Joseph J. Eron; Joel E. Gallant; Marybeth McCauley; Theresa Gamble; Mina C. Hosseinipour; Nagalingeswaran Kumarasamy; James G. Hakim; Jose H. Pilotto; Johnstone Kumwenda; Victor Akelo; Sheela V. Godbole; Breno R. Santos; Beatriz Grinsztejn; Ravindre Panchia; Suwat Chariyalertsak; Joseph Makhema; Sharlaa Badal-Faesen; Ying Q. Chen; Myron S. Cohen; Susan H. Eshleman
1-Jun-2020Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative studyNicolas Folschweiller; Julio Teixeira; Smita Joshi; Luciano Z. Goldani; Khuanchai Supparatpinyo; Partha Basu; Tawee Chotpitayasunondh; Ploenchan Chetchotisakd; Kiat Ruxrungtham; Cecilia Roteli-Martins; Beatriz Grinsztejn; Silvana Maria Quintana; Nagalingeswaran Kumarasamy; Selvamuthu Poongulali; Vinay Kulkarni; Lan Lin; Sanjoy K. Datta; Dominique Descamps; Monique Dodet; Gary Dubin; Damien Friel; Marjan Hezareh; Naveen Karkada; Dorothee Meric Camilleri; Sylviane Poncelet; Bruno Salaun; Fernanda Tavares-da-Silva; Florence Thomas-Jooris; Frank Struyf
18-Jul-2018Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabineDavid V. Glidden; Kathleen Mulligan; Vanessa McMahan; Peter L. Anderson; Juan Guanira; Suwat Chariyalertsak; Susan P. Buchbinder; Linda Gail Bekker; Mauro Schechter; Beatriz Grinsztejn; Robert M. Grant
26-Sep-2019Phylogenetic Methods Inconsistently Predict the Direction of HIV Transmission Among Heterosexual Pairs in the HPTN 052 CohortRebecca Rose; Matthew Hall; Andrew D. Redd; Susanna Lamers; Andrew E. Barbier; Stephen F. Porcella; Sarah E. Hudelson; Estelle Piwowar-Manning; Marybeth McCauley; Theresa Gamble; Ethan A. Wilson; Johnstone Kumwenda; Mina C. Hosseinipour; James G. Hakim; Nagalingeswaran Kumarasamy; Suwat Chariyalertsak; Jose H. Pilotto; Beatriz Grinsztejn; Lisa A. Mills; Joseph Makhema; Breno R. Santos; Ying Q. Chen; Thomas C. Quinn; Christophe Fraser; Myron S. Cohen; Susan H. Eshleman; Oliver Laeyendecker
1-Oct-2015Pre-cART elevation of CRP and CD4<sup>+</sup>t-cell immune activation associated with HIV clinical progression in a multinational case-cohort studyAshwin Balagopal; David M. Asmuth; Wei Teng Yang; Thomas B. Campbell; Nikhil Gupte; Laura Smeaton; Cecilia Kanyama; Beatriz Grinsztejn; Breno Santos; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Javier R. Lama; Umesh G. Lalloo; Fatima Zulu; Jyoti S. Pawar; Cynthia Riviere; Nagalingeswaran Kumarasamy; James Hakim; Xiao Dong Li; Richard B. Pollard; Richard D. Semba; David L. Thomas; Robert C. Bollinger; Amita Gupta
11-Aug-2011Prevention of HIV-1 infection with early antiretroviral therapyMyron S. Cohen; Ying Q. Chen; Marybeth McCauley; Theresa Gamble; Mina C. Hosseinipour; Nagalingeswaran Kumarasamy; James G. Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H.S. Pilotto; Sheela V. Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R. Santos; Kenneth H. Mayer; Irving F. Hoffman; Susan H. Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A. Mills; Guy De Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E. Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R. Fleming
16-Jul-2011Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trialJean Michel Molina; Pedro Cahn; Beatriz Grinsztejn; Adriano Lazzarin; Anthony Mills; Michael Saag; Khuanchai Supparatpinyo; Sharon Walmsley; Herta Crauwels; Laurence T. Rimsky; Simon Vanveggel; Katia Boven
1-Jan-2015Strong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: Implications for pre-exposure prophylaxis adherence monitoringMonica Gandhi; David V. Glidden; Albert Liu; Peter L. Anderson; Howard Horng; Patricia Defechereux; Juan V. Guanira; Beatriz Grinsztejn; Suwat Chariyalertsak; Linda Gail Bekker; Robert M. Grant
1-Sep-2019Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn; Michael D. Hughes; Justin Ritz; Robert Salata; Peter Mugyenyi; Evelyn Hogg; Linda Wieclaw; Robert Gross; Catherine Godfrey; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Faesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Anchalee Avihingsanon; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; B. Grinsztejn; P. N. Mugyenyi; A. Collier; R. Salata; C. Godfrey; E. Hogg; M. Hughes; J. Ritz; L. Wieclaw; T. Sise; J. W. Mellors; C. Wallis; C. V. Fletcher; M. Gandhi; R. Gross; R. T. Schooley; R. Walensky; M. van Schalkwyk; S. Faesen; R. Mngqibisa; J. Valencia; E. Montalban; N. Kumarasamy; C. Kanyama; S. W. Cardoso; B. R. Santos; B. Mansfield; H. Mugerwa; B. W. Ndege; R. Secours; W. Samaneka; D. Kadam; V. Mave; M. Makanga; S. N. Fontain; P. Sugandhavesa; A. Avihingsanon; L. Nakibuuka; H. Nassolo; P. Anthony; V. Kulkarni; M. Nsubuga; J. van Wyk; J. Rooney; Y. van Delft; R. Leavitt; R. Luk; A. Benns; L. Hovind; A. Shahkolahi
1-Jun-2022Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trialAnchalee Avihingsanon; Michael D. Hughes; Robert Salata; Catherine Godfrey; Caitlyn McCarthy; Peter Mugyenyi; Evelyn Hogg; Robert Gross; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Badal-aesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije Van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Cornelius Munyanga; Maganizo Chagomerana; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; Beatriz Grinsztejn
1-Jan-2017Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 TrialSusan H. Eshleman; Sarah E. Hudelson; Andrew D. Redd; Ronald Swanstrom; San San Ou; Xinyi Cindy Zhang; Li Hua Ping; Estelle Piwowar-Manning; Stephen F. Porcella; Matthew F. Sievers; Craig A. Martens; Daniel Bruno; Elena Dukhovlinova; Marybeth McCauley; Theresa Gamble; Jessica M. Fogel; Devin Sabin; Thomas C. Quinn; Laurence Gunde; Madalitso Maliwichi; Nehemiah Nhando; Victor Akelo; Sikhulile Moyo; Ravindre Panchia; Nagalingeswaran Kumarasamy; Nuntisa Chotirosniramit; Marineide Gonçalves De Melo; Jose Pilotto; Beatriz Grinsztejn; Kenneth Mayer; Ying Q. Chen; James P. Hughes; Myron S. Cohen
15-Nov-2013Undisclosed antiretroviral drug use in a multinational clinical trial (HIV prevention trials network 052)Jessica M. Fogel; Lei Wang; Teresa L. Parsons; San San Ou; Estelle Piwowar-Manning; Ying Chen; Victor O. Mudhune; Mina C. Hosseinipour; Johnstone Kumwenda; James G. Hakim; Suwat Chariyalertsak; Ravindre Panchia; Ian Sanne; Nagalingeswaran Kumarasamy; Beatriz Grinsztejn; Joseph Makhema; Jose Pilotto; Breno R. Santos; Kenneth H. Mayer; Marybeth McCauley; Theresa Gamble; Namandjé N. Bumpus; Craig W. Hendrix; Myron S. Cohen; Susan H. Eshleman
4-May-2017Virologic outcomes in early antiretroviral treatment: HPTN 052Susan H. Eshleman; Ethan A. Wilson; Xinyi C. Zhang; San San Ou; Estelle Piwowar-Manning; Joseph J. Eron; Marybeth McCauley; Theresa Gamble; Joel E. Gallant; Mina C. Hosseinipour; Nagalingeswaran Kumarasamy; James G. Hakim; Ben Kalonga; Jose H. Pilotto; Beatriz Grinsztejn; Sheela V. Godbole; Nuntisa Chotirosniramit; Breno Riegel Santos; Emily Shava; Lisa A. Mills; Ravindre Panchia; Noluthando Mwelase; Kenneth H. Mayer; Ying Q. Chen; Myron S. Cohen; Jessica M. Fogel
Showing results 6 to 24 of 24 < previous